Release Date: 25/02/19 17:21 Summary: Half Yearly Report and Accounts Price Sensitive: Yes Download Document 912.21KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%